LMNA公司
基因组不稳定性
生物
癌症研究
拉明
核板
细胞生物学
DNA损伤
遗传学
转录因子
核蛋白
基因
DNA
作者
Christopher W. Schultz,Sourav Saha,Anjali Dhall,Yang Zhang,Parth Desai,Lőrinc Sándor Pongor,David A. Scheiblin,Valentin Magidson,Ravi Prakash Shukla,Robin Sebastian,Umeshkumar Vekariya,Samreen Ahmed,Yilun Sun,Christophe E. Redon,Suresh Kumar,Manan Krishnamurthy,Henrique Bregolin Dias,Vasilisa Aksenova,Elizabeth Giordano,Nobuyuki Takahashi
标识
DOI:10.1073/pnas.2503387122
摘要
Lamin A/C ( LMNA ), a key component of the nuclear envelope, is essential for maintaining nuclear integrity and genome organization [W. Xie et al. , Curr. Biol. 26 , 2651–2658 (2016)]. While LMNA dysregulation has been implicated in genomic instability across cancer and aging, the underlying mechanisms remain poorly understood [S. Graziano et al. , Nucleus 9 , 258–275 (2018)]. Here, we define a mechanistic role for LMNA in preserving genome stability in small-cell lung cancer (SCLC), a malignancy marked by extreme genomic instability [N. Takahashi et al. , Cancer Res. Commun. 2 , 503–517 (2022)]. LMNA depletion promotes R-loop accumulation, transcription-replication conflicts, replication stress, DNA breaks, and micronuclei formation. Mechanistically, LMNA deficiency disrupts nuclear pore complex organization, specifically reducing phenylalanine-glycine (FG)-nucleoporin incorporation, resulting in impaired RNA export and nuclear retention of RNA. LMNA expression is repressed by EZH2 and reexpressed during SCLC differentiation from neuroendocrine (NE) to non-NE states, and low LMNA levels correlate with poor clinical outcomes. These findings establish LMNA as a key regulator of nuclear transport and genome integrity, linking nuclear architecture to SCLC progression and therapeutic vulnerability.
科研通智能强力驱动
Strongly Powered by AbleSci AI